ArticleDrug delivery and translational research2020

QbD aided development of ibrutinib-loaded nanostructured lipid carriers aimed for lymphatic targeting: evaluation using chylomicron flow blocking approach.

Nagarjun Rangaraj et al.PubMed ↗Publisher ↗

No numbers read from the abstract.